Rheuma Gen announced it raised $4.91 Million in an initial filing from an offering of $15 Million

Apr 17, 2024•over 1 year ago

Amount Raised

$4.91 Million

Round Type

seed

DenverBiotechnology

Company Information

Company

RheumaGen

Location

200 QUEBEC ST.

Denver, Colorado, United States

About

RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases. RheumaGen focuses on editing the human leukocyte antigen (HLA), or "immune gene," to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado.

Related People

2 contacts

Rheuma Gen announced it raised $4.91 Million in an initial filing from an offering of $15 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information